What is it about?
In the CORAL clinical trial of stenting versus optimal medical management for renal artery stenosis, revascularization provided no benefit on kidney function decline over time or clinical events for CKD or CVD. Patients managed medically did just as well as those who received stents irrespective of bilateral or unilateral disease or baseline kidney function.
Featured Image
Why is it important?
This study shows that optimal medical management of atherosclerotic risk factors is appropriate treatment for most patients with renal artery stenosis seen in clinical practice.
Read the Original
This page is a summary of: Effects of Stenting for Atherosclerotic Renal Artery Stenosis on eGFR and Predictors of Clinical Events in the CORAL Trial, Clinical Journal of the American Society of Nephrology, May 2016, American Society of Nephrology,
DOI: 10.2215/cjn.10491015.
You can read the full text:
Contributors
The following have contributed to this page